Dr. Robin Armstrong was catapulted into the media limelight after he began administering hydroxychloroquine to nursing home patients as a treatment for COVID-19. The drug has received widespread attention since it emerged as a possible solution in the midst of the ongoing pandemic.
In this podcast, Dr. Armstrong sits down for a remote interview with The Texan’s CEO and Founder Konni Burton. In the course of their conversation, Dr. Armstrong addresses why he administered the drug, its effectiveness in treating positive cases, and what else can be done in the battle against the coronavirus.
The Resort at Texas City, a Galveston County nursing home where Armstrong serves as the medical director, recently saw as many as 87 positive cases of the coronavirus between residents and staff.
“We decided that we would try and shelter these persons in place — keep them in their nursing facility… because the mortality rate for elderly people in the hospital is extremely high,” said Armstrong. “Hydroxychloroquine, azithromycin, and zinc were the only options there.”
“We figured that the safety profile for these medications was actually pretty good because they’d been around for a long time,” he continued.
Out of 38 elderly patients treated using this method, only one died of COVID-19. The treatment regimen lasts just five days.
Watch the full interview with Dr. Armstrong below:
Disclosure: Unlike almost every other media outlet, The Texan is not beholden to any special interests, does not apply for any type of state or federal funding, and relies exclusively on its readers for financial support. If you’d like to become one of the people we’re financially accountable to, click here to subscribe.
Ben Billups is the Marketing Manager for The Texan. After earning his degree in Economics from Thomas Edison State University, he served as a policy analyst for Texas’ 85th Legislature and later operated an outlet for veteran investigative journalists. Ben is a native Texan, an award-winning filmmaker, and actively competes in Brazilian Jiu-Jitsu.